![]() |
市场调查报告书
商品编码
1399747
家庭护理制氧机市场 - 按产品(便携式製氧机、固定制氧机)、按技术(连续流、脉衝流) - 全球预测,2023-2032 年Homecare Oxygen Concentrators Market - By Product (Portable Oxygen Concentrators, Fixed Oxygen Concentrators), By Technology (Continuous Flow, Pulse Flow) - Global Forecast, 2023-2032 |
在呼吸系统疾病盛行率上升、转向家庭医疗保健以及医疗技术进步的推动下,全球家庭护理制氧机市场预计在 2023 年至 2032 年期间CAGR为 6%。
根据非传染性疾病联盟 2022 年发布的报告,全球有近 5.5 亿成年人患有慢性呼吸道疾病,数字持续上升。随着越来越多的人被诊断出患有慢性阻塞性肺病(COPD)和气喘等慢性呼吸系统疾病,对居家氧气治疗的需求不断增加。
此外,根据Visual Capitalist公布的资料,2022年,全球65岁及以上人口达到7.71亿,占全球人口的近10%,预计到2050年将激增至16%。全球人口老化、生活方式疾病和呼吸系统疾病的易感性增加,促进了产品的采用。
家用制氧机产业根据产品、技术和地区进行分类。
由于效率、降噪和用户友好功能方面的创新,固定制氧机领域预计将在预测期内为行业成长做出重大贡献。该产品不仅确保持续可靠的氧气供应,还提高了患者的舒适度和可及性。此外,现代固定式氧气机配备了更长的电池寿命,增强了设备的可用性,使患者在日常活动中具有更大的灵活性,而无需频繁充电。
脉衝流技术领域预计到 2032 年将实现稳定成长,因为它透过脉衝或爆发式输送氧气来运行,与患者的呼吸模式保持一致。这种创新方法可确保在需要时精确供氧,从而节省资源并提高治疗的整体效果。此外,与连续流设备相比,脉衝流设备通常设计得更紧凑、更轻,这最终增强了患者的活动能力,使个人能够更轻鬆地从事日常活动。
在该地区庞大的人口和不断发展的医疗基础设施的推动下,亚太地区家庭护理制氧机行业将在研究期间经历强劲增长。在中国和印度等国家,人们越来越关注家庭医疗保健解决方案。这一因素,加上支持家庭医疗保健解决方案和医疗设备补贴的政策,鼓励了可近性和采用,从而塑造了区域市场前景。
The Global Homecare Oxygen Concentrators Market is expected to register 6% CAGR during 2023-2032, fueled by the rising prevalence of respiratory disorders, shift towards home based healthcare, and advancements in medical technologies.
According to a report published by NCD Alliance in 2022, globally, almost 550 million adults grapple with chronic respiratory diseases, and this number is consistently on the ascent. With an increasing number of individuals diagnosed with chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma, the demand for home-based oxygen therapy is on the rise.
Furthermore, as per the data published by Visual Capitalist, in 2022, the global population aged 65 years and above reached 771 million, constituting nearly 10% of the world's populace and it is projected to surge to 16% by the year 2050. As the global population ages, the susceptibility to lifestyle diseases as well as respiratory conditions increases, boosting the product adoption.
The homecare oxygen concentrators industry is classified based on product, technology, and region.
The fixed oxygen concentrators segment is expected to contribute substantially towards industry growth during the forecast period owing to innovations in terms of efficiency, noise reduction, and user-friendly features. The product not only ensures a continuous and reliable oxygen supply but also provides enhanced patient comfort and accessibility. Moreover, modern fixed oxygen concentrators are equipped with extended battery life which enhances the device's usability, allowing patients greater flexibility in their daily activities without the constraints of frequent recharging.
The pulse flow technology segment is expected to witness a steady growth through 2032 as it operates by delivering oxygen in pulses or bursts, aligning with the patient's breathing pattern. This innovative approach ensures oxygen is administered precisely when needed, conserving resources and enhancing the overall effectiveness of therapy. Moreover, the pulse flow devices are often designed to be more compact and lightweight compared to continuous flow devices, which ultimately enhances patient mobility, allowing individuals to engage in daily activities with greater ease.
Asia Pacific homecare oxygen concentrators industry is poised to experience robust growth during the study period driven by region's expansive population and evolving healthcare infrastructure. In countries like China and India, there is increasing focus on home-based healthcare solutions. This factor, along with policies supporting home-based healthcare solutions and subsidies for medical devices, have encouraged accessibility and adoption, thus shaping the regional market outlook.